Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ozurdex in diabetic macular edema
NCT00168337Phase 3Completed
- Sponsor
- Allergan
- Start
- May 2005
- Primary completion
- May 2012
- Countries
- 14
01
Overview
A Phase 3 trial of ozurdex in diabetic macular edema (DME), sponsored by Allergan. Started May 2005; status: completed.
02
Drugs
ozurdex
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT00168337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00168337.